{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:19:23Z","timestamp":1792181963235,"version":"4.4.0"},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Applied Toxicology"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug repositioning is an approach that could accelerate the clinical use of compounds in different diseases. The goal is to take advantage of the fact that approved drugs have been tested on humans and detailed information is available on their pharmacology, toxicity and formulation. It can significantly reduce the costs and time needed to implement necessary therapies on the market. In recent years, phenothiazines are being tested for cancer, viral, bacterial, fungal and other diseases. Most research focuses on chlorpromazine as a model drug in this class, but other drugs such as fluphenazine, perphenazine and prochlorperazine have been proven to inhibit the viability of different cancer cell lines. In this study, we performed an extensive literature search to find and summarize all papers on the chosen phenothiazines and their potential in treating different types of cancer<jats:italic>in vitro<\/jats:italic> for further animal\/clinical trials. Fluphenazine, perphenazine and prochlorperazine possess anticancer activity towards different types of human cancer. The antitumor activity is mainly mediated by an effect of the drugs on the cell cycle, proliferation or apoptosis. Possible molecular targets of phenothiazine derivatives are the drug's efflux pumps (ABCB1 and P\u2010glycoprotein) and two parallel pathways (AKT and Wnt) regulated by the D<jats:sub>2<\/jats:sub> receptor antagonists. The drugs have the potential to reduce the viability of human cancer cell lines, fragment the DNA, stimulate apoptosis, inhibit cell migration and invasiveness as well as impair the production of reactive oxygen species. In addition, due to the sedative and antiemetic properties antipsychotics can be used as an adjuvant for the treatment of chemotherapy side effects.<\/jats:p>","DOI":"10.1002\/jat.4046","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T14:49:33Z","timestamp":1599058173000},"page":"82-94","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["<i>In vitro<\/i> anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review"],"prefix":"10.1002","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-7737","authenticated-orcid":false,"given":"Micha\u0142","family":"Otr\u0119ba","sequence":"first","affiliation":[{"name":"Department of Drug Technology Medical University of Silesia, Katowice Faculty of Pharmaceutical Sciences in Sosnowiec  Sosnowiec Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-9813","authenticated-orcid":false,"given":"Leon","family":"Ko\u015bmider","sequence":"additional","affiliation":[{"name":"Department of General and Inorganic Chemistry Medical University of Silesia, Katowice Faculty of Pharmaceutical Sciences in Sosnowiec  Sosnowiec Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"24","article-title":"A review on pharmacological\/biological activities of different derivatives of phenothiazines","volume":"2","author":"Arya D. K.","year":"2013","journal-title":"International Journal of Environment & Animal Conservation"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.77"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2015.01.002"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1414.041"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2015.02.004"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0026-895X(25)10091-6","article-title":"Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance","volume":"35","author":"Ford J. M.","year":"1989","journal-title":"Molecular Pharmacology"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:22:3:189"},{"key":"e_1_2_8_9_1","first-page":"107","article-title":"Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth","volume":"15","author":"Gil\u2010Ad I.","year":"2006","journal-title":"Oncology Reports"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26725"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65093"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(85)90374-0"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.05.031"},{"key":"e_1_2_8_14_1","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03367572?term=prochlorperazine&cond=cancer&draw=2&rank=1"},{"key":"e_1_2_8_15_1","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00335647?term=fluphenazine&cond=cancer&draw=2&rank=1"},{"key":"e_1_2_8_16_1","unstructured":"https:\/\/ec.europa.eu\/eurostat\/statistics\u2010explained\/index.php\/Cancer_statistics_\u2010_specific_cancers"},{"key":"e_1_2_8_17_1","unstructured":"https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0\u20100$1\u2010AE28$4\u20101 2$3\u2010All$6\u20100 14$5\u20132008 2008$7\u20137$CEstByCancer$X0_8\u20133$CEstRelativeCanc$X1_8\u20133$X1_9\u2010AE28"},{"key":"e_1_2_8_18_1","unstructured":"https:\/\/www.cancer.gov\/about\u2010cancer\/treatment\/clinical\u2010trials\/search\/v?id=NCI\u20102013\u201000093&r=1."},{"key":"e_1_2_8_19_1","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"e_1_2_8_20_1","first-page":"582221","article-title":"Control of the endo\u2010lysosome homeostasis by the paracaspase MALT1 regulates glioma cell survival","volume":"1","author":"Jacobs K. A.","year":"2019","journal-title":"BioRxiv."},{"key":"e_1_2_8_21_1","article-title":"Repurposing sertraline sensitizes non\u2010small cell lung cancer cells to erlotinib by inducing autophagy","volume":"3","author":"Jiang X.","year":"2018","journal-title":"Journal of Clinical Investigation Insight."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13525"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12837"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12830"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.130"},{"key":"e_1_2_8_26_1","first-page":"1508","article-title":"Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin","volume":"6","author":"Krishan A.","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.200"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-018-0206-4"},{"key":"e_1_2_8_29_1","first-page":"19","article-title":"Perphenazine and prochlorperazine induce concentration\u2010dependent loss in human glioblastoma cells viability","volume":"73","author":"Otr\u0119ba M.","year":"2018","journal-title":"Pharmazie"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-019-01668-5"},{"key":"e_1_2_8_31_1","first-page":"903","article-title":"Fluphenazine and perphenazine impact on melanogenesis and antioxidant enzymes activity in normal human melanocytes","volume":"73","author":"Otr\u0119ba M.","year":"2016","journal-title":"Acta Poloniae Pharmaceutica. Drug Research"},{"key":"e_1_2_8_32_1","first-page":"171","article-title":"Prochlorperazine interaction with melanin and melanocytes","volume":"72","author":"Otr\u0119ba M.","year":"2017","journal-title":"Pharmazie"},{"key":"e_1_2_8_33_1","first-page":"1101","article-title":"Preliminary studies on phenothiazine\u2010mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells","volume":"19","author":"Pajak B.","year":"2005","journal-title":"In Vivo"},{"key":"e_1_2_8_34_1","first-page":"447","article-title":"Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics","volume":"58","author":"Schulz M.","year":"2003","journal-title":"Pharmazie"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.05.023"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.9224"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236003"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)91145-2"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1022"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11153"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040955"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.15-0707"},{"key":"e_1_2_8_44_1","first-page":"1043","article-title":"In vitro novel combinations of psychotropics and anti\u2010cancer modalities in U87 human glioblastoma cells","volume":"37","author":"Tzadok S.","year":"2010","journal-title":"International Journal of Oncology"},{"key":"e_1_2_8_45_1","first-page":"5983","article-title":"Possible biological and clinical applications of phenothiazines","volume":"37","author":"Varga B.","year":"2017","journal-title":"Anticancer Research"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00483-2"},{"key":"e_1_2_8_47_1","first-page":"459","article-title":"Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases","volume":"9","author":"Xu F.","year":"2019","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.62"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.56"}],"container-title":["Journal of Applied Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jat.4046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jat.4046","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jat.4046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:42:33Z","timestamp":1760542953000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jat.4046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1002\/jat.4046"],"URL":"https:\/\/doi.org\/10.1002\/jat.4046","archive":["Portico"],"relation":{},"ISSN":["0260-437X","1099-1263"],"issn-type":[{"value":"0260-437X","type":"print"},{"value":"1099-1263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"2020-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}